Overview
Olaf-oliver Wolz practices practicing medicine in Tuebingen, Germany.
Their clinical expertise encompasses COVID-19, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Olaf-oliver Wolz
Is Olaf-oliver Wolz a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Olaf-oliver Wolz is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Olaf-oliver Wolz participate in research or clinical trials?
Yes. Olaf-oliver Wolz has published 18 articles and abstracts on conditions like COVID-19. You can view a list of Olaf-oliver Wolz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaWolz isExperienced. Learn about B-Cell Lymphoma.
- COVID-19Wolz isExperienced. Learn about COVID-19.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaWolz isExperienced. Learn about Non-Hodgkin Lymphoma.